WallStreetZenWallStreetZen

NASDAQ: ANNX
Annexon Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANNX

Based on 5 analysts offering 12 month price targets for Annexon Inc.
Min Forecast
$10.00+125.23%
Avg Forecast
$16.20+264.86%
Max Forecast
$30.00+575.68%

Should I buy or sell ANNX stock?

Based on 5 analysts offering ratings for Annexon Inc.
Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANNX stock forecasts and price targets.

ANNX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2024-04-01Find Out Why
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-03-27

1 of 1

Forecast return on equity

Is ANNX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is ANNX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ANNX revenue forecast

What is ANNX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$33.5M
Avg 2 year Forecast
$73.9M
Avg 3 year Forecast
$210.6M

ANNX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANNX$4.44$16.20+264.86%Strong Buy
TRDA$11.91$21.00+76.32%Buy
BMEA$11.16$55.80+400.00%Buy
LXRX$1.63N/AN/A
TRML$15.66$61.80+294.64%Strong Buy

Annexon Stock Forecast FAQ

Is Annexon Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ANNX) stock is to Strong Buy ANNX stock.

Out of 5 analysts, 3 (60%) are recommending ANNX as a Strong Buy, 2 (40%) are recommending ANNX as a Buy, 0 (0%) are recommending ANNX as a Hold, 0 (0%) are recommending ANNX as a Sell, and 0 (0%) are recommending ANNX as a Strong Sell.

If you're new to stock investing, here's how to buy Annexon stock.

What is ANNX's revenue growth forecast for 2025-2027?

(NASDAQ: ANNX) Annexon's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Annexon's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast ANNX's revenue for 2025 to be $3,016,756,951, with the lowest ANNX revenue forecast at $1,069,503,807, and the highest ANNX revenue forecast at $4,964,010,095. On average, 3 Wall Street analysts forecast ANNX's revenue for 2026 to be $6,656,760,944, with the lowest ANNX revenue forecast at $1,530,434,741, and the highest ANNX revenue forecast at $12,904,265,634.

In 2027, ANNX is forecast to generate $18,960,285,930 in revenue, with the lowest revenue forecast at $18,960,285,930 and the highest revenue forecast at $18,960,285,930.

What is ANNX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ANNX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ANNX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ANNX price target, the average ANNX price target is $16.20, with the highest ANNX stock price forecast at $30.00 and the lowest ANNX stock price forecast at $10.00.

On average, Wall Street analysts predict that Annexon's share price could reach $16.20 by Apr 11, 2025. The average Annexon stock price prediction forecasts a potential upside of 264.86% from the current ANNX share price of $4.44.

What is ANNX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ANNX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.